🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 02/03/1989 | 0,0652 USD |
| 29/11/1988 | 0,0588 USD |
| 29/08/1988 | 0,0469 USD |
| 03/06/1988 | 0,0509 USD |
| 29/02/1988 | 0,0509 USD |
| 01/12/1987 | 0,0424 USD |
| 28/08/1987 | 0,0424 USD |
| 02/06/1987 | 0,0292 USD |
| 02/03/1987 | 0,0292 USD |
| 02/12/1986 | 0,0292 USD |
| 02/09/1986 | 0,0292 USD |
| 03/06/1986 | 0,0239 USD |
| 27/02/1986 | 0,0239 USD |
| 03/12/1985 | 0,0239 USD |
| 30/08/1985 | 0,0212 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 15/05/2017 | 60,52 | 60,69 | 60,44 | 60,60 | -0,09% | 0,41% | 8.710.347 |
| 12/05/2017 | 61,44 | 61,71 | 60,37 | 60,66 | -1,33% | 2,17% | 10.838.521 |
| 11/05/2017 | 61,78 | 62,26 | 61,36 | 61,48 | +0,77% | 1,45% | 19.404.663 |
| 10/05/2017 | 60,24 | 61,02 | 60,20 | 61,01 | +1,03% | 1,36% | 10.094.126 |
| 09/05/2017 | 61,24 | 61,33 | 60,27 | 60,39 | -1,12% | 1,73% | 10.712.970 |
| 08/05/2017 | 60,98 | 61,56 | 60,91 | 61,08 | +0,06% | 1,06% | 11.684.676 |
| 05/05/2017 | 60,59 | 61,15 | 60,52 | 61,04 | +0,93% | 1,04% | 9.795.237 |
| 04/05/2017 | 60,75 | 60,96 | 60,32 | 60,48 | -0,39% | 1,05% | 9.023.280 |
| 03/05/2017 | 59,64 | 60,75 | 59,52 | 60,72 | +1,48% | 2,06% | 11.978.430 |
| 02/05/2017 | 59,65 | 60,34 | 59,46 | 59,83 | +0,51% | 1,49% | 13.647.580 |
| 01/05/2017 | 59,40 | 59,64 | 59,26 | 59,52 | +0,08% | 0,64% | 10.707.521 |
| 28/04/2017 | 59,71 | 59,78 | 59,29 | 59,48 | -0,40% | 0,81% | 9.915.862 |
| 27/04/2017 | 59,90 | 60,03 | 59,59 | 59,71 | -0,19% | 0,73% | 6.920.258 |
| 26/04/2017 | 59,76 | 60,00 | 59,57 | 59,83 | +0,64% | 0,72% | 9.284.546 |
| 25/04/2017 | 59,63 | 60,05 | 59,40 | 59,45 | +0,26% | 1,09% | 11.205.006 |
| 24/04/2017 | 59,64 | 59,66 | 59,18 | 59,29 | +0,40% | 0,80% | 9.270.922 |
| 21/04/2017 | 59,50 | 59,76 | 59,04 | 59,06 | -1,06% | 1,22% | 11.002.323 |
| 20/04/2017 | 59,79 | 59,88 | 59,40 | 59,69 | -0,14% | 0,80% | 9.392.490 |
| 19/04/2017 | 59,41 | 59,77 | 59,16 | 59,77 | +0,59% | 1,03% | 10.845.857 |
| 18/04/2017 | 59,60 | 59,60 | 59,15 | 59,42 | -0,84% | 0,75% | 7.749.436 |
| 17/04/2017 | 59,84 | 59,96 | 59,53 | 59,92 | +0,30% | 0,72% | 5.590.242 |
| 13/04/2017 | 59,91 | 60,11 | 59,69 | 59,74 | -0,70% | 0,70% | 6.217.260 |
| 12/04/2017 | 59,51 | 60,31 | 59,43 | 60,16 | +0,75% | 1,49% | 9.965.642 |
| 11/04/2017 | 59,63 | 59,89 | 59,33 | 59,71 | +0,05% | 0,93% | 6.858.950 |
| 10/04/2017 | 60,37 | 60,43 | 59,67 | 59,69 | -0,92% | 1,26% | 7.595.590 |
| 07/04/2017 | 60,38 | 60,43 | 60,07 | 60,24 | -0,17% | 0,60% | 8.091.713 |
| 06/04/2017 | 60,57 | 61,04 | 60,30 | 60,34 | -0,52% | 1,23% | 7.915.125 |
| 05/04/2017 | 60,77 | 61,21 | 60,60 | 60,66 | -0,16% | 1,00% | 8.083.538 |
| 04/04/2017 | 60,68 | 60,85 | 60,47 | 60,75 | +0,32% | 0,63% | 6.650.189 |
| 03/04/2017 | 60,52 | 60,79 | 60,32 | 60,56 | -0,11% | 0,77% | 6.962.493 |